MedTech Compliance Bootcamp
This carefully curated program will provide you with a comprehensive understanding of the current compliance framework.
Code of Ethics
Learn more about our Code of Ethics.
2022 Revised AdvaMed® Code Presentation
A comprehensive training deck that companies can pull from depending on the setting and need.
AdvaMed® Code Crosswalk
A “Crosswalk” comparing the revised AdvaMed® Code with the other codes of ethics, to include: PhRMA; Medtech Europe; and Mecomed.
Device Industry Ethics Code Evolves as Care Approach, Government Scrutiny, Change
The AdvaMed® Code helps guide medical technology companies to develop and structure internal controls and self-regulatory principles in a way that addresses important legal risks.
AdvaMed® Approves Updated Code of Ethics
The AdvaMed® Board of Directors has approved revisions to the AdvaMed® Code of Ethics on Interactions with Health Care Professionals in the U.S., effective June 1, 2022.
AdvaMed® Continues to Lead the Way in Compliance and Ethics with Revised Code of Ethics
AdvaMed®, the world’s largest trade organization representing medical technology manufacturers, today announced that its board of directors has unanimously approved revisions to the AdvaMed® Code of Ethics on Interactions with Health Care Professionals.
AdvaMed® Code Of Ethics on Interactions With Health Care Professionals in India
The AdvaMed® India Code of Ethics provides medical technology and diagnostics manufacturers with compliance principles and guidance that address the key legal risk areas governing business relationships and activities.
Compliance & Ethics
To ensure collaborative relationships between medtech companies and health care professionals meet the highest ethical standards, the AdvaMed® Code of Ethics provides guidance based on six cornerstone values: innovation, education,…
AdvaMed® Comments to OIG-128-N
AdvaMed® submitted proposals for additional or modified safe harbor provisions under the federal Anti-Kickback Statute.
AdvaMed® Letter Regarding HCIC RFI on AKS Final Rule
AdvaMed® submitted feedback regarding safe harbor revisions under the federal Anti-Kickback Statute.